Original Contributions |
From the Cardiovascular Biology Laboratory, Harvard School of Public Health (A.P., P.W., L.C.F., G.S.H., S.-F.Y., M.A.P.), the Department of Medicine, Harvard Medical School (A.S., G.S.H., M.A.P.), the Cardiac Unit, Massachusetts General Hospital (G.S.H.), and the Pulmonary and Critical Care Division, Brigham and Women's Hospital (A.S., M.A.P.), Boston, Mass.
Correspondence to Mark A. Perrella, MD, Cardiovascular Biology Laboratory, Building 2, Harvard School of Public Health, 677 Huntington Ave, Boston, MA 02115. E-mail perrella{at}cvlab.harvard.edu
AbstractHeme oxygenase (HO)-1 generates CO, a gas with vasodilatory properties, during heme metabolism. HO-1 is expressed highly in vascular tissue after endotoxin stimulation, and generation of CO through the HO-1 pathway contributes to the hemodynamic compromise of endotoxic shock. Shock related to endotoxemia is an immune-mediated process that involves the generation of proinflammatory cytokines such as interleukin (IL)-1ß. Because transforming growth factor (TGF)-ß1 is a modulator of immune-mediated inflammatory responses and it blocks the hypotension of endotoxic shock, we determined whether TGF-ß1 could be used to reduce expression of HO-1 in vascular tissue and smooth muscle cells. In a rat model of endotoxic shock, lipopolysaccharide-induced HO-1 mRNA and protein expression was reduced by TGF-ß1 in highly vascularized tissue, such as heart and lung, by Northern and Western analysis. Furthermore, TGF-ß1 downregulated HO-1 mRNA after its induction by IL-1ß in vascular smooth muscle cells in culture. TGF-ß1 also decreased HO-1 but not HO-2 protein expression in these cells. TGF-ß1 decreased HO enzyme activity induced in IL-1ßtreated vascular smooth muscle cells to a level not different from that in vehicle-treated cells. These studies suggest that this downregulation of HO-1 mRNA and protein expression and decrease in IL-1ßinduced HO enzyme activity may contribute to the beneficial effect of TGF-ß1 on endotoxic shock.
Key Words: vascular smooth muscle cell endotoxic shock gene expression enzyme activity
This article has been cited by other articles:
![]() |
Y. Wei, X.-m. Liu, K. J. Peyton, H. Wang, F. K. Johnson, R. A. Johnson, and W. Durante Hypochlorous acid-induced heme oxygenase-1 gene expression promotes human endothelial cell survival Am J Physiol Cell Physiol, October 1, 2009; 297(4): C907 - C915. [Abstract] [Full Text] [PDF] |
||||
![]() |
Q. Ye, Y. Dalavanga, N. Poulakis, S. U. Sixt, J. Guzman, and U. Costabel Decreased expression of haem oxygenase-1 by alveolar macrophages in idiopathic pulmonary fibrosis Eur. Respir. J., May 1, 2008; 31(5): 1030 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Stocker and M. A. Perrella Heme Oxygenase-1: A Novel Drug Target for Atherosclerotic Diseases? Circulation, November 14, 2006; 114(20): 2178 - 2189. [Full Text] [PDF] |
||||
![]() |
S. W. Chung, Y.-H. Chen, S.-F. Yet, M. D. Layne, and M. A. Perrella Endotoxin-Induced Down-Regulation of Elk-3 Facilitates Heme Oxygenase-1 Induction in Macrophages J. Immunol., February 15, 2006; 176(4): 2414 - 2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Chung, Y.-H. Chen, and M. A. Perrella Role of Ets-2 in the Regulation of Heme Oxygenase-1 by Endotoxin J. Biol. Chem., February 11, 2005; 280(6): 4578 - 4584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Szabo, E. Gallyas, I. Bak, A. Rakotovao, F. Boucher, J. de Leiris, N. Nagy, E. Varga, and A. Tosaki Heme Oxygenase-1-Related Carbon Monoxide and Flavonoids in Ischemic/Reperfused Rat Retina Invest. Ophthalmol. Vis. Sci., October 1, 2004; 45(10): 3727 - 3732. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Sikorski, T. Hock, N. Hill-Kapturczak, and A. Agarwal The story so far: molecular regulation of the heme oxygenase-1 gene in renal injury Am J Physiol Renal Physiol, March 1, 2004; 286(3): F425 - F441. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. A. D. T. G. Wagener, H.-D. Volk, D. Willis, N. G. Abraham, M. P. Soares, G. J. Adema, and C. G. Figdor Different Faces of the Heme-Heme Oxygenase System in Inflammation Pharmacol. Rev., September 1, 2003; 55(3): 551 - 571. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Chen, S.-F. Yet, and M. A. Perrella Role of Heme Oxygenase-1 in the Regulation of Blood Pressure and Cardiac Function Exp Biol Med, May 1, 2003; 228(5): 447 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Wiesel, A. P. Patel, N. DiFonzo, P. B. Marria, C. U. Sim, A. Pellacani, K. Maemura, B. W. LeBlanc, K. Marino, C. M. Doerschuk, et al. Endotoxin-Induced Mortality Is Related to Increased Oxidative Stress and End-Organ Dysfunction, Not Refractory Hypotension, in Heme Oxygenase-1-Deficient Mice Circulation, December 12, 2000; 102(24): 3015 - 3022. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. DiChiara, J. M. Kiely, M. A. Gimbrone Jr., M.-E. Lee, M. A. Perrella, and J. N. Topper Inhibition of E-Selectin Gene Expression by Transforming Growth Factor {beta} in Endothelial Cells Involves Coactivator Integration of Smad and Nuclear Factor {kappa}B-Mediated Signals J. Exp. Med., September 5, 2000; 192(5): 695 - 704. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M Shah Inducible nitric oxide synthase and cardiovascular disease Cardiovasc Res, January 1, 2000; 45(1): 148 - 155. [Full Text] [PDF] |
||||
![]() |
P. Wiesel, L. C. Foster, A. Pellacani, M. D. Layne, C.-M. Hsieh, G. S. Huggins, P. Strauss, S.-F. Yet, and M. A. Perrella Thioredoxin Facilitates the Induction of Heme Oxygenase-1 in Response to Inflammatory Mediators J. Biol. Chem., August 4, 2000; 275(32): 24840 - 24846. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hill-Kapturczak, L. Truong, V. Thamilselvan, G. A. Visner, H. S. Nick, and A. Agarwal Smad7-dependent Regulation of Heme Oxygenase-1 by Transforming Growth Factor-beta in Human Renal Epithelial Cells J. Biol. Chem., December 22, 2000; 275(52): 40904 - 40909. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-F. Yet, R. Tian, M. D. Layne, Z. Y. Wang, K. Maemura, M. Solovyeva, B. Ith, L. G. Melo, L. Zhang, J. S. Ingwall, et al. Cardiac-Specific Expression of Heme Oxygenase-1 Protects Against Ischemia and Reperfusion Injury in Transgenic Mice Circ. Res., July 20, 2001; 89(2): 168 - 173. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Research Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1998 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |